282 related articles for article (PubMed ID: 29465703)
1. An Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users.
Roth AM; Aumaier BL; Felsher MA; Welles SL; Martinez-Donate AP; Chavis M; Van Der Pol B
Sex Transm Dis; 2018 Apr; 45(4):217-221. PubMed ID: 29465703
[TBL] [Abstract][Full Text] [Related]
2. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
Walters SM; Coston B; Neaigus A; Rivera AV; Starbuck L; Ramirez V; Reilly KH; Braunstein SL
Int J Drug Policy; 2020 Mar; 77():102671. PubMed ID: 32092665
[TBL] [Abstract][Full Text] [Related]
3. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC.
Kuo I; Olsen H; Patrick R; Phillips G; Magnus M; Opoku J; Rawls A; Peterson J; Hamilton F; Kharfen M; Greenberg A
Drug Alcohol Depend; 2016 Jul; 164():8-13. PubMed ID: 27177804
[TBL] [Abstract][Full Text] [Related]
4. Examining unmet needs: a cross-sectional study exploring knowledge, attitudes and sexually transmitted infection screening preferences among persons who inject drugs in Camden, New Jersey.
Roth A; Tran NK; Chavis M; Van Der Pol B
Sex Transm Infect; 2018 Dec; 94(8):598-603. PubMed ID: 29960982
[TBL] [Abstract][Full Text] [Related]
5. Perceptions of people who inject drugs towards HIV pre-exposure prophylaxis in Australia.
Read P; Chronister KJ; Kostovski C; Harrod ME; Salmon A; Jauncey M
Sex Health; 2019 Aug; 16(4):383-388. PubMed ID: 31203837
[TBL] [Abstract][Full Text] [Related]
6. Integrating HIV Preexposure Prophylaxis With Community-Based Syringe Services for Women Who Inject Drugs: Results From the Project SHE Demonstration Study.
Roth AM; Tran NK; Felsher M; Gadegbeku AB; Piecara B; Fox R; Krakower DS; Bellamy SL; Amico KR; Benitez JA; Van Der Pol B
J Acquir Immune Defic Syndr; 2021 Mar; 86(3):e61-e70. PubMed ID: 33148998
[TBL] [Abstract][Full Text] [Related]
7. Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs.
Vincent W; McFarland W
Int J Drug Policy; 2022 Dec; 110():103873. PubMed ID: 36252292
[TBL] [Abstract][Full Text] [Related]
8. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
[TBL] [Abstract][Full Text] [Related]
9. Estimated proportion of an urban academic emergency department patient population eligible for HIV preexposure prophylaxis.
Faryar KA; Ancona RM; Braun RS; Brown JL; Sickles RK; Lyons MS
Am J Emerg Med; 2021 Oct; 48():198-202. PubMed ID: 33975131
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Preexposure (PrEP) Eligibility Criteria, Using Sexually Transmissible Infections as Markers of Human Immunodeficiency Virus (HIV) Risk at Enrollment in PrEPX, a Large Australian HIV PrEP Trial.
Cornelisse VJ; Fairley CK; Stoove M; Asselin J; Chow EPF; Price B; Roth NJ; Willcox J; Tee BK; Penn M; Chang CC; Armishaw J; Forgan-Smith G; Wright EJ;
Clin Infect Dis; 2018 Nov; 67(12):1847-1852. PubMed ID: 29741665
[TBL] [Abstract][Full Text] [Related]
11. Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria.
Nishimoto L; Ikani P; Achanya J; Idowu A; Olisa AL; Walker CF; Gottlieb A; Akolo C
Glob Health Sci Pract; 2023 Feb; 11(1):. PubMed ID: 36853631
[TBL] [Abstract][Full Text] [Related]
12. Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
Bazzi AR; Biancarelli DL; Childs E; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Biello KB
AIDS Patient Care STDS; 2018 Dec; 32(12):529-537. PubMed ID: 30311777
[TBL] [Abstract][Full Text] [Related]
13. Study protocol for an efficacy trial of the "PrEP for Health" intervention to increase HIV PrEP use among people who inject drugs.
Bazzi AR; Bordeu M; Baumgartner K; Sproesser DM; Bositis CM; Krakower DS; Mimiaga MJ; Biello KB
BMC Public Health; 2023 Mar; 23(1):513. PubMed ID: 36932369
[TBL] [Abstract][Full Text] [Related]
14. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland.
Sherman SG; Schneider KE; Park JN; Allen ST; Hunt D; Chaulk CP; Weir BW
Drug Alcohol Depend; 2019 Feb; 195():148-155. PubMed ID: 30639794
[TBL] [Abstract][Full Text] [Related]
15. HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.
Walters SM; Kral AH; Simpson KA; Wenger L; Bluthenthal RN
Subst Use Misuse; 2020; 55(14):2409-2419. PubMed ID: 32962490
[TBL] [Abstract][Full Text] [Related]
16. Inequities Along the Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Services Continuum for Black Women in the United States, 2015-2020.
Townes A; Tanner MR; Yu L; Johnson WD; Zhu W; Iqbal K; Dominguez KL; Henny KD; Drezner K; Schumacher C; Bickham J; Elopre L; Edelstein ZR; Hoover KW;
Obstet Gynecol; 2024 Feb; 143(2):294-301. PubMed ID: 37963384
[TBL] [Abstract][Full Text] [Related]
17. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
[TBL] [Abstract][Full Text] [Related]
18. Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US.
Underhill K; Morrow KM; Colleran CM; Holcomb R; Operario D; Calabrese SK; Galárraga O; Mayer KH
PLoS One; 2014; 9(11):e112425. PubMed ID: 25386746
[TBL] [Abstract][Full Text] [Related]
19. Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP.
Calabrese SK; Willie TC; Galvao RW; Tekeste M; Dovidio JF; Safon CB; Blackstock O; Taggart T; Kaplan C; Caldwell A; Kershaw TS
J Acquir Immune Defic Syndr; 2019 Aug; 81(4):395-405. PubMed ID: 30973543
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: Use of Pre-Exposure Prophylaxis to Prevent Rapid HIV Transmission Among People Who Inject Drugs in Rural Counties in the United States: A Modeling Study.
Jacka BP; Nolen S; Bessey SE; Zang X; Goedel WC; Yedinak JL; Marshall BDL
J Acquir Immune Defic Syndr; 2022 Dec; 91(5):449-452. PubMed ID: 36150038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
